Hybridoma cells are created by fusing B lymphocytes and myeloma cells, resulting in cells that produce monoclonal antibodies. B lymphocytes are essential for immunity, while myeloma cells are cancerous. The process was developed in the 1970s and involves immunizing a mouse, isolating B lymphocytes, fusing them with myeloma cells, and selecting for cells that recognize […]